To assess the effect of antiretroviral therapy on HIV/AIDS patients at art plus center Bhopal: a retro respective study

Hemant Verma, Bhavishya Rathore, Jeetandra Sharma, Manju Toppo


Background: To assess the immunological and clinical progress of human immunodeficiency virus/acquired immune deficiency syndrome patients on antiretroviral therapy at antiretroviral therapy (ART) center Bhopal, Madhya Pradesh, India.

Methods: Retrospective medical records review was conducted to determine the immunological and clinical progress of HIV/AIDS patients. The records of patients on their clinical stage, cluster of differentiation 4 (CD4) Count, and working status were reviewed.

Results: A total number of 5295 patients were included in the study. The mean age was 33.39 Years and standard deviation 11.84 years; it ranged from 0.5 to 82years. Number of males was 3441 (64.98%), females formed 1829 (34.54%), while transgender 25 (0.47%). Out of 5295 patients 3314 (%) are eligible and initiated ART. And out of 3314 patients, 1903 patients continue to be present at their follow up visit for regular clinical and pathological checkup. The mean weight of the patients increased from 49.59kg to 52.41 after 12 months of therapy. Mean CD4 cell counts as 231cells/mm3 during the first follow up increase to 443 cells/mm3 at 2nd visit. Before ART 674 Patients were working and 373 were bedridden and after 1 year of ART 1028 were became belongs to working group and only 197 were remains bedridden. Percentage of patients in stage III became 38.94% (from 48.84%) followed by Stage II 38.36% (from 23.08%).

Conclusions: Study concluded that the patients taken ART were shown to experience improved health status in general. 



Full Text:



WHO. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Guidelines for a Public Health Approach. Geneva: WHO. 2002:19.

Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA. Declining Morbidity and Mortality among Patients with Advanced HIV Infection - HIV Out-Patients Study Investigations. N Engl J Med. 1998;338:853-60.

Erb P, Battegay M, Zimmerli W, Rickenbach M, Egger M. Effects of Antiretroviral Therapy on Viral Load, CD4 Cell Count and Progression of Acquired Immunodeficiency Syndrome in a Community of HIV-Infected Cohort Study. Arch Intern Med. 2000;160:1134-40.

Paterson DL, Swindell S, Mohr J, Brester M, Vergis E, Squire S. Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection. Ann Intern Med. 2000;133:21-30.

Cloyd MW, Moore BE. Spectrum of biological properties of Human Immunodeficiency virus (HIV-1) isolates. Virology. 1990;174:103-16.

Available at:

Li H, Zheng Y, Chen Z. Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients. Zhonghua Yi Xue Za Zhi. 2007;87:2973-6.

Zhou HY, Zheng YH, He Y, et al. Evaluation of a 6-year highly active antiretroviral therapy in Chinese HIV-1 infected patients. Intervirology. 2010;53:240-6.

Ormaasen V, Sandvik L, Dudman SG, Bruun JN. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population. Scand J Infect Dis. 2007;39:51-54.

Glencross DK, Janossy G, and Coetzee LM. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom. 2008;74(1):S131-40.

Clinical progression of severely immunosuppressed

HIV-infected patients depends on virological and immunological improvement irrespective of baseline status Elena Ferrer, Jordi Curto, Anna Esteve, Jose M. Miro, Cristina Tural, Javier Murillas, Ferran Segura, Pilar Barrufet, Jordi Casabona and Daniel Podzamczer on behalf of the PISCIS Investigators. 2015.

Urge DG, Legesse T. Study of immune response in HIV/ AIDS patients to HAART using CD4 count progress at six months of therapy initiation. EDCTP Fourth Annual Forum, 2007. Available from: poster.pdf.